前收市價 | 63.53 |
開市 | 64.28 |
買盤 | 63.20 x 400 |
賣出價 | 63.27 x 200 |
今日波幅 | 63.22 - 64.28 |
52 週波幅 | 56.05 - 100.77 |
成交量 | |
平均成交量 | 2,464,991 |
市值 | 11.48B |
Beta 值 (5 年,每月) | 1.23 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -1.13 |
業績公佈日 | 2024年5月08日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 90.76 |
In the latest trading session, Exact Sciences (EXAS) closed at $63.24, marking a -0.46% move from the previous day.
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]
Exact Sciences' (EXAS) first-quarter 2024 performance is expected to include gains from robust Cologuard uptake and continuing Oncotype DX growth, offset slightly by increasing operating costs.